Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Hepato-Gastroenterology|September 26, 2006
Impact of pegylated interferon alfa-2a and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open-label seriesSandeep Mukherjee, Elizabeth LydenWorld Journal of Hepatology|February 7, 2022
Targets of immunotherapy for hepatocellular carcinoma: An updateVikrant Rai, Sandeep MukherjeeJournal of Transplantation|February 5, 2010
A comprehensive review of immunosuppression used for liver transplantationSandeep Mukherjee, Urmila MukherjeeExpert Review of Clinical Pharmacology|June 19, 2014
Antiviral therapy for chronic hepatitis C in 2014Manogna Nookathota, Sandeep MukherjeeLiver International : Official Journal of the International Association for the Study of the Liver|June 10, 2006
Impact of pegylated interferon alpha-2B and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open-label seriesSandeep Mukherjee, Elizabeth LydenExpert Review of Clinical Pharmacology|November 6, 2012
The adverse pharmacology of calcineurin inhibitors and their impact on hepatitis C recurrence after liver transplantation: implications for clinical practiceMauricio Garcia-Saenz-de-Sicilia, Sandeep MukherjeeWorld Journal of Gastrointestinal Surgery|February 7, 2022
Current status of liver transplantation for cholangiocarcinomaPatrick Twohig, Thoetchai Bee Peeraphatdit, Sandeep MukherjeeCurrent Drug Targets|June 13, 2009
Immunosuppression in liver transplantationSandeep Mukherjee, Jean F Botha, Urmila MukherjeeHepato-Gastroenterology|March 2, 2006
Comparison of indocyanine green clearance with Child's-Pugh score and hepatic histology: a multivariate analysisSandeep Mukherjee, Mary A M Rogers, Borys BuniakHepatology (Baltimore, Md.)|July 29, 2003
Ethanol metabolism results in a G2/M cell-cycle arrest in recombinant Hep G2 cellsDahn L Clemens, Lilian E Calisto, Michael F Sorrell, et al.Pageof 6